Trump tariff threat spurs domestic pharmaceutical manufacturing

This year, major pharmaceutical companies are set to invest a remarkable $500 billion in American research and manufacturing, driven by President Trump's warning of steep tariffs if they don't increase domestic production. This move not only highlights the importance of local manufacturing but also promises to create jobs and boost the economy, making it a significant development in the industry.